Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 11:08 PM
NCT ID:
NCT02696967
Pre Assignment Details:
Patients were assigned to one of the 2 treatment arms in fixed randomization ratio (CLR325: Placebo):
* Cohort 1: Single dose of CLR325 2.5 mcg/kg/min (i.v.) or placebo (i.v.)
* Cohort 2: Single dose of CLR325 0.25 mcg/kg/min (i.v.) or placebo (i.v.)
* Cohort 3: Single dose of CLR325 8 mcg/kg/min (i.v.) or placebo (i.v.)
Recruitment Details:
This study was conducted in 11 centers in 5 countries: Belgium (1), Germany (2), Netherlands (1), Singapore (1) and USA (6).
Study:
NCT02696967
Study Brief:
Results Section:
NCT02696967